{
    "type": "VariantTherapeuticResponseProposition",
    "predicate": "sensitivity",
    "description": "In combination with dabrafenib, for the treatment of pediatric patients 1 year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation who require systemic therapy",
    "geneContextQualifier": "BRAF",
    "objectTherapeutic": "Trametinib [Mekinist]"
}